1. Home
  2. AGL vs NHS Comparison

AGL vs NHS Comparison

Compare AGL & NHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo agilon health inc.

AGL

agilon health inc.

N/A

Current Price

$0.77

Market Cap

270.4M

Sector

Health Care

ML Signal

N/A

Logo Neuberger Berman High Yield Strategies Fund

NHS

Neuberger Berman High Yield Strategies Fund

N/A

Current Price

$7.48

Market Cap

217.9M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
AGL
NHS
Founded
2016
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
270.4M
217.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
AGL
NHS
Price
$0.77
$7.48
Analyst Decision
Hold
Analyst Count
17
0
Target Price
$2.77
N/A
AVG Volume (30 Days)
5.8M
111.8K
Earning Date
02-24-2026
01-01-0001
Dividend Yield
N/A
13.44%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,885,571,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.21
N/A
52 Week Low
$0.51
$6.95
52 Week High
$6.08
$9.17

Technical Indicators

Market Signals
Indicator
AGL
NHS
Relative Strength Index (RSI) 55.80 66.45
Support Level $0.67 $7.15
Resistance Level $0.82 $7.49
Average True Range (ATR) 0.05 0.08
MACD 0.01 0.04
Stochastic Oscillator 61.32 97.73

Price Performance

Historical Comparison
AGL
NHS

About AGL agilon health inc.

Agilon Health Inc is transforming healthcare by empowering primary care physicians for the health of the patients. The company enables physicians to create their own Medicare-centric globally capitated line of business. The company derives its revenue from Medical services.

About NHS Neuberger Berman High Yield Strategies Fund

Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.

Share on Social Networks: